MediXall (MDXL) Profit After Tax (2019 - 2024)
MediXall's Profit After Tax history spans 8 years, with the latest figure at $263813.0 for Q3 2024.
- For Q3 2024, Profit After Tax rose 129.05% year-over-year to $263813.0; the TTM value through Sep 2024 reached -$2.2 million, up 55.78%, while the annual FY2023 figure was -$4.6 million, 33.19% up from the prior year.
- Profit After Tax reached $263813.0 in Q3 2024 per MDXL's latest filing, up from -$485862.0 in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $263813.0 in Q3 2024 to a low of -$2.4 million in Q1 2022.
- Average Profit After Tax over 5 years is -$1.3 million, with a median of -$1.3 million recorded in 2021.
- Peak YoY movement for Profit After Tax: plummeted 80.9% in 2022, then skyrocketed 129.05% in 2024.
- A 5-year view of Profit After Tax shows it stood at -$2.0 million in 2020, then rose by 7.64% to -$1.8 million in 2021, then increased by 1.95% to -$1.8 million in 2022, then rose by 18.4% to -$1.5 million in 2023, then soared by 118.14% to $263813.0 in 2024.
- Per Business Quant, the three most recent readings for MDXL's Profit After Tax are $263813.0 (Q3 2024), -$485862.0 (Q2 2024), and -$486600.0 (Q1 2024).